Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024
October 16, 2024 16:35 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
On the Heels of Historic Hurricane Helene, American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Hurricane Milton
October 10, 2024 13:07 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 10, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has turned on its Disaster Relief Program to aid dialysis and post-transplant patients living in areas impacted by...
Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
October 09, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 09, 2024 07:00 ET
|
Purespring Therapeutics
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 09, 2024 02:00 ET
|
Purespring Therapeutics
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...
E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment
October 08, 2024 09:00 ET
|
E-Star Biotech
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney...
American Kidney Fund Hosts ‘Dialysis at Home’ Summit to Share Knowledge and Resources about Home Dialysis with the Kidney Community
October 03, 2024 09:12 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) is hosting the third annual Dialysis at Home summit, a free, online event in which participants will hear from...
Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief Program
October 02, 2024 09:48 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- In the wake of the devastation of Hurricane Helene across the Southeast, the American Kidney Fund’s (AKF) Disaster Relief Program is continuing to...
Comprehensive Analysis of Genitourinary Collaboration and Licensing Deals (2016-2024) Unveiled
September 25, 2024 09:20 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Genitourinary Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The genitourinary therapeutic...
Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024
September 24, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...